Literature DB >> 22863384

Adrenal incidentaloma.

Giorgio Arnaldi1, Marco Boscaro.   

Abstract

Adrenal incidentaloma is a common clinical problem and its prevalence, in radiological studies, comes close to that of autoptic data as a result of imaging technological advances. The diagnostic challenge is to distinguish the majority of benign lesions from other masses, either malignant or hormone secreting, which require further therapy. The imaging evaluation (unenhanced CT and MRI) can differentiate malignant to benign lesions because the benign lesions have high lipid content. All patients should be tested for hypercortisolism and pheochromocytoma whereas aldosteronism should be tested in hypertensive patients only. The optimal diagnostic management for adrenal incidentaloma is still controversial, and the endocrinologist must devise a cost-effective approach taking into account the extensive endocrine work-up and imaging investigations that may be necessary. A tailored strategy may be based on the selection of patients at increased risk who require a careful and extensive follow-up among the vast majority of patients who require a simplified follow-up.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22863384     DOI: 10.1016/j.beem.2011.12.006

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  33 in total

1.  Non-functioning adrenal incidentalomas caused by 21-hydroxylase deficiency or carrier status?

Authors:  Henrik Falhammar
Journal:  Endocrine       Date:  2014-01-23       Impact factor: 3.633

Review 2.  Development of adrenal cortex zonation.

Authors:  Yewei Xing; Antonio M Lerario; William Rainey; Gary D Hammer
Journal:  Endocrinol Metab Clin North Am       Date:  2015-06       Impact factor: 4.741

Review 3.  Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment.

Authors:  Victoria L Martucci; Karel Pacak
Journal:  Curr Probl Cancer       Date:  2014-01-15       Impact factor: 3.187

4.  First-line screening tests for Cushing's syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS/MS.

Authors:  F Ceccato; G Antonelli; A C Frigo; D Regazzo; M Plebani; M Boscaro; C Scaroni
Journal:  J Endocrinol Invest       Date:  2017-02-28       Impact factor: 4.256

Review 5.  Diagnosis and management of pheochromocytoma: a practical guide to clinicians.

Authors:  Joseph M Pappachan; Diana Raskauskiene; Rajagopalan Sriraman; Mahamood Edavalath; Fahmy W Hanna
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

Review 6.  MicroRNAs in adrenal tumors: relevance for pathogenesis, diagnosis, and therapy.

Authors:  Peter Igaz; Ivan Igaz; Zoltán Nagy; Gábor Nyírő; Peter M Szabó; András Falus; Attila Patócs; Károly Rácz
Journal:  Cell Mol Life Sci       Date:  2014-10-09       Impact factor: 9.261

7.  Investigation of N-cadherin/β-catenin expression in adrenocortical tumors.

Authors:  Beatrice Rubin; Daniela Regazzo; Marco Redaelli; Carla Mucignat; Marilisa Citton; Maurizio Iacobone; Carla Scaroni; Corrado Betterle; Franco Mantero; Ambrogio Fassina; Raffaele Pezzani; Marco Boscaro
Journal:  Tumour Biol       Date:  2016-07-28

Review 8.  Anti-hypertensive treatment in pheochromocytoma and paraganglioma: current management and therapeutic features.

Authors:  Alberto Mazza; Michela Armigliato; Maria Cristina Marzola; Laura Schiavon; Domenico Montemurro; Giorgio Vescovo; Marco Zuin; Sotirios Chondrogiannis; Roberta Ravenni; Giuseppe Opocher; Patrick M Colletti; Domenico Rubello
Journal:  Endocrine       Date:  2013-07-02       Impact factor: 3.633

Review 9.  Genetics and epigenetics of adrenocortical tumors.

Authors:  Antonio M Lerario; Andreas Moraitis; Gary D Hammer
Journal:  Mol Cell Endocrinol       Date:  2013-11-09       Impact factor: 4.102

10.  Clinical investigation of pituitary incidentalomas: A two-center study.

Authors:  Kota Ishii; Ichiro Abe; Wataru Kameda; Kaoru Sugimoto; Yusuke Morinaga; Miiko Ito; Yuichi Takashi; Makiko Abe; Yurika Hada; Kaoru Takase; Hideyuki Fujii; Hanako Ohishi; Kentaro Ochi; Yuka Yamao; Midori Minezaki; Tadachika Kudo; Toshio Higashi; Yukihiko Sonoda; Kenichi Ishizawa; Kunihisa Kobayashi
Journal:  Intractable Rare Dis Res       Date:  2019-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.